Amendment to round lots for certain Danish equities effective from today 25 June 2008


Due to an error in the calculation of the biannually review of the round lots
it has been necessary to make a recalculation resulting in changes for seven
Danish equities: D/S Norden, DSV, Genmab, NKT Holding, Novo Nordisk B,
Coloplast B and Bang & Olufsen B. 

Please see the enclosed.

Attachments

2008_06_24_nasdaq omx copenhagen_updated new round lot_uk.pdf